Nuveen LLC Invests $1.84 Million in AVANOS MEDICAL, INC. $AVNS

Nuveen LLC bought a new position in shares of AVANOS MEDICAL, INC. (NYSE:AVNS) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 128,365 shares of the company’s stock, valued at approximately $1,839,000. Nuveen LLC owned approximately 0.28% of AVANOS MEDICAL as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Clark Estates Inc. NY acquired a new position in AVANOS MEDICAL in the first quarter valued at about $7,077,000. Pacer Advisors Inc. acquired a new position in AVANOS MEDICAL in the first quarter valued at about $6,056,000. Brown Advisory Inc. raised its stake in AVANOS MEDICAL by 12.0% in the fourth quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company’s stock valued at $30,329,000 after purchasing an additional 204,218 shares in the last quarter. Diamond Hill Capital Management Inc. acquired a new position in AVANOS MEDICAL in the first quarter valued at about $2,800,000. Finally, D. E. Shaw & Co. Inc. raised its stake in AVANOS MEDICAL by 43.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 494,627 shares of the company’s stock valued at $7,874,000 after purchasing an additional 148,902 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

AVANOS MEDICAL Stock Up 0.5%

Shares of NYSE AVNS opened at $11.93 on Friday. The company has a current ratio of 2.64, a quick ratio of 1.58 and a debt-to-equity ratio of 0.12. The company has a market cap of $553.74 million, a price-to-earnings ratio of -1.19 and a beta of 1.12. AVANOS MEDICAL, INC. has a 12 month low of $9.30 and a 12 month high of $25.36. The stock has a 50-day moving average price of $11.62 and a two-hundred day moving average price of $12.82.

AVANOS MEDICAL (NYSE:AVNS) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The business had revenue of $175.00 million for the quarter, compared to analyst estimates of $165.50 million. AVANOS MEDICAL had a positive return on equity of 6.16% and a negative net margin of 66.89%.During the same period in the previous year, the firm posted $0.34 EPS. AVANOS MEDICAL has set its FY 2025 guidance at 0.750-0.950 EPS. As a group, analysts forecast that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on AVNS shares. Zacks Research raised AVANOS MEDICAL to a “hold” rating in a research note on Tuesday, August 12th. Wall Street Zen downgraded AVANOS MEDICAL from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Insider Buying and Selling

In other AVANOS MEDICAL news, Director Gary Blackford bought 40,000 shares of the stock in a transaction on Wednesday, August 13th. The stock was purchased at an average price of $10.99 per share, with a total value of $439,600.00. Following the completion of the purchase, the director owned 40,000 shares in the company, valued at $439,600. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.64% of the company’s stock.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.